Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity.
Kageji H, Momose T, Ebisawa M, Nakazawa Y, Okada H, Togashi N, Nagamoto Y, Obuchi W, Yasumatsu I, Kihara K, Hiramoto K, Minami M, Kasanuki N, Isoyama T, Naito H, Tanaka N.
Kageji H, et al. Among authors: kihara k.
Bioorg Med Chem. 2024 Sep 1;111:117862. doi: 10.1016/j.bmc.2024.117862. Epub 2024 Jul 30.
Bioorg Med Chem. 2024.
PMID: 39111073